Get started
Author

Ana Faria

Observed names: A Faria, A. Faria, A.L. Faria, Ana Luísa L. Faria
Observed institutions: Royal Marsden NHS Foundation Trust, Unidade Local de Saúde de Entre Douro e Vouga, IPO Porto, Royal Marsden Hospital, Hospital da Luz, Hospital Beatriz Ângelo
ORCID: 0000-0002-7881-2151
Observed ORCID: 0000-0002-7881-2151
OpenAlex ID: A5069615039
Treatment options for small cell lung cancer – do we have more choice?
2010 · M Puglisi, S Dolly, et al. · British Journal of Cancer · 112
PDF
ONKOTEV Score as a Predictive Tool for Thromboembolic Events in Pancreatic Cancer—A Retrospective Analysis
2019 · João Godinho, Mafalda Casa-Nova, et al. · The Oncologist · 29
Febrile Neutropenia in Patients with Solid Tumors Undergoing Intravenous Chemotherapy
2020 · João Moreira-Pinto, Inês Leão, et al. · Oncology Research and Treatment · 15
Triple M Overlap Syndrome: Myocarditis, Myositis and Myasthenia Gravis After a Single Administration of Pembrolizumab
2025 · Carlota Baptista, Inês Margarido, et al. · Cureus · 12
PDF
Loss of RAS Mutations in Liquid Biopsies of Patients With Multi-Treated Metastatic Colorectal Cancer
2023 · Joana Albuquerque, Diana Neto da Silva, et al. · The Oncologist · 5
PDF
CYP3A5*3 genotypes and advanced non-small cell lung cancer development
2007 · A. Nogal, A. Coelho, et al. · Journal of Clinical Oncology · 3
Phenotype-Genotype Correlation in Colorectal Cancer: A Real-Life Study
2021 · Catarina Frias-Gomes, Ana Carla Sousa, et al. · GE Portuguese Journal of Gastroenterology · 2
The value of day 8 blood count in treatment decisions when using oral vinorelbine in non-small cell lung cancer
2010 · J.S. Myerson, A. Faria, et al. · Lung Cancer · 1
P-171 Prognostic value of conversion from RAS-mutated to RAS wild-type during treatment of metastatic colorectal cancer using liquid biopsies – real-world data of two Portuguese institutions
2022 · J. Albuquerque, D. Neto da Silva, et al. · Annals of Oncology
Fr334 AGRIN PROTEIN AS A MOLECULAR PROGNOSTIC BIOMARKER IN PANCREATIC DUCTAL ADENOCARCINOMA
2021 · Barbara Morão, Maria Pia Costa Santos, et al. · Gastroenterology
What’s The Odds: Beta-Human Chorionic Gonadotropin in Lung Cancer and Complete Response to Third Line Nivolumab
2021 · Áurea Lima, Alcinda Reis, et al. · Clinical Oncology: Case Reports
P09.02 Impact of COVID-19 in Portuguese Lung Cancer Patients’ Treatment: Portuguese Lung Cancer Study Group Survey
2021 · F. Estevinho, A. Figueiredo, et al. · Journal of Thoracic Oncology
PDF
Adherence to a combined exercise and dietary intervention in patients with gastrointestinal cancer undergoing neo-adjuvant therapy.
2020 · S. Velho, S. Rodrigues, et al. · Clinical Nutrition ESPEN
410P Extent of lymph node (LN) resection and tumour sidedness in operable colon cancer (CC) stage and survival
2020 · P. Simões, A. Faria, et al. · Annals of Oncology
The value of day 8 blood count in treatment decisions when using oral vinorelbine in non-small cell lung cancer (NSCLC) patients
2009 · A. Faria, J.S. Myerson, et al. · Lung Cancer
P1-217: Retrospective study about using topotecan in second-line treatment of small-cell lung cancer. Experience of a single institution, from 2002 to 2006
2007 · Ana Luísa L. Faria, António Araújo, et al. · Journal of Thoracic Oncology
PD2-3-8: -2518 MCP-1 and Interleukin-4 VNTR polymorphisms and NSCLC risk
2007 · Ana P. Coelho, António Araújo, et al. · Journal of Thoracic Oncology
Works count: 17
Citation count: 179
H-index: 5
I10-index: 4
Year
Topic
Type